Germany's WOM (World of Medicine) prepares for return to Berlin
This article was originally published in Clinica
Executive Summary
German listed company World of Medicine (WOM) will propose to move its headquarters back to Berlin at its AGM in June, after six years of being based in Ludwigstadt/Oberfranken, in Bavaria. Under CEO Peter Wiest, the company transferred to the southern town in 2001, at the time of its IPO, but it now wants to return to its roots to benefit from proximity to its customers, universities and R&D institutes, and to be nearer to the political decision-making. Berlin houses an estimated 80 medtech companies and 70 clinics, along with its four universities and seven technical high schools.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.